Cannabinoid Liquid Formulation Vaporization for Rapid Absorption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional methods of cannabinoid administration, such as smoking cannabis cigarettes, expose users to harmful respiratory toxins and have inefficiencies in delivering cannabinoids effectively, while existing vaporization techniques may not provide rapid enough absorption and satisfaction.
Innovation Solution
Cannabinoid liquid formulations comprising a cannabinoid extract dissolved in a solvent with a biologically acceptable liquid carrier, such as glycerol or propylene glycol, are used in an electronic cigarette, which heats the formulation to generate an inhalable aerosol with specific solvent properties like vapor pressure and boiling point differences, ensuring efficient transfer and rapid absorption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If traditional cannabis cigarettes are used for cannabinoid administration, then users experience pain relief and therapeutic benefits, but users are exposed to harmful respiratory toxins and tar
Solution Approach 1:
The patent utilizes phase transition by heating the cannabinoid formulation to a temperature where active cannabinoid vapors form (phase change from liquid to vapor), but below the point of combustion. This allows the cannabinoid to be delivered in vaporized form without reaching combustion temperatures that produce harmful toxins and tar, thus resolving the contradiction between effective delivery and harmful exposure
Solution Approach 2:
The patent changes the temperature parameter to a specific range that enables vaporization of cannabinoids without combustion. By controlling the heating temperature to be below the combustion point, the system achieves effective cannabinoid delivery while avoiding the formation of harmful respiratory toxins and tar that occur at higher combustion temperatures
2Object-affected harmful factors
If cannabinoid vaporization is used to avoid harmful toxins, then exposure to respiratory toxins is reduced, but absorption rate and onset speed may be insufficient
Solution Approach 1:
The patent employs phase transition from liquid to vapor to enhance absorption speed. By vaporizing the cannabinoid formulation, the active compounds are delivered in gaseous form that can be rapidly absorbed through the lungs, achieving fast onset comparable to or exceeding traditional combustion methods while maintaining the benefit of reduced toxic exposure
Solution Approach 2:
The patent replaces the mechanical combustion process with a controlled vaporization system. Instead of burning the cannabinoid material, an electronic heating element vaporizes the liquid formulation, substituting a controlled thermal-mechanical process for uncontrolled combustion. This substitution enables rapid absorption through efficient vapor delivery while avoiding the harmful byproducts of combustion
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method provides superior pain relief and therapeutic benefits with faster cannabinoid absorption and higher user satisfaction compared to traditional methods, achieving comparable results to smoking cannabis cigarettes with potentially higher absorption rates and quicker onset.
Implementation Method 1
heating the cannabinoid formulation, described herein, to a temperature where active cannabinoid vapors form
Implementation Method 2
generate an inhalable aerosol with specific solvent properties like vapor pressure and boiling point differences
Data Source
AI summary
The disclosure provides methods, formulations, and apparatus for making and using cannabinoid formulations.